2,5-Dioxopyrrolidin-1-yl propanoate
| Code | Size | Price |
|---|
| CDX-D0489-M250 | 250 mg | £169.00 |
Quantity:
| CDX-D0489-M500 | 500 mg | £267.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
AMBIENT
Storage:
+4°C
Documents
Further Information
Alternate Names/Synonyms:
N-(Propionyloxy)succinimide; N-succinimidyl propionate; NSP; Propionyl-Osu; 1-(1-Oxopropoxy)-2,5-pyrrolidinedione
Appearance:
White to off-white powder.
CAS:
30364-55-7
EClass:
32160000
Form (Short):
liquid
GHS Symbol:
GHS07
Handling Advice:
Protect from light and moisture.
Hazards:
H315, H319, H335
InChi:
InChI=1S/C7H9NO4/c1-2-7(11)12-8-5(9)3-4-6(8)10/h2-4H2,1H3
InChiKey:
AASBXERNXVFUEJ-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 30364-55-7. Formula: C7H9NO4. MW: 171.15. Synthetic. Biochemical for proteomics research use. Amine-specific protein-acylating agent. Used for derivatization of biogenic amines for hplc analysis. Recent stuides use this agent for derivatization of histone post-translational modifications. The compound has been used in several studies describing this well established reagent for the introduction of a tritium label into proteins or other biologicals. The retrograde transport of protein components of sciatic nerve axons has been demonstrated by direct labelling of the protein usingNSP in vivo.
MDL:
MFCD03427483
Molecular Formula:
C7H9NO4
Molecular Weight:
171.15
Package Type:
Vial
Precautions:
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P332+P313, P337+P313, P362, P403+P233, P405, P501
Product Description:
Biochemical for proteomics research use. Amine-specific protein-acylating agent. Used for derivatization of biogenic amines for hplc analysis. Recent stuides use this agent for derivatization of histone post-translational modifications. The compound has been used in several studies describing this well established reagent for the introduction of a tritium label into proteins or other biologicals. The retrograde transport of protein components of sciatic nerve axons has been demonstrated by direct labelling of the protein using [3H]NSP in vivo.
Purity:
>95%
Signal word:
Warning
SMILES:
CCC(ON1C(CCC1=O)=O)=O
Solubility Chemicals:
Soluble in chloroform.
Source / Host:
Synthetic.
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at +4°C.
References
(1) J.C. Hedreen & G.C. Holm; Brain Res. Bull. 7, 665 (1981) | (2) Y.S. Tang; J. Labelled Comp. Radiopharm. 20, 277 (1982) | (3) U. Kummer; Meth. Enzymol. 121, 670 (1986) | (4) R. Liao, et al.; Anal. Chem. 85, 2253 (2013) | (5) J.Chen, et al.; Anal. Chim. Acta 886, 107 (2015)
Related Products
| Product Name | Product Code | Supplier | 6,7-Dihydroxy-4-coumarinylacetic acid | CDX-D0029 | Chemodex | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6,7-Dimethoxy-4-(trifluoromethyl) coumarin | CDX-D0033 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6,7-Dimethoxy-4-coumarinylacetic acid | CDX-D0034 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7-Diethylaminocoumarin-3-carboxylic acid | CDX-D0036 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7-Diethylaminocoumarin-3,4-dicarboxylic acid | CDX-D0039 | Chemodex | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||